UY28959A1 - Compuestos basados en bispidinas, 3,7-diazabiciclo (3,3,1)nonanos, particularmente oxabispidinas, sus sales y solvatos, composiciones conteniéndolos y procedimientos de preparación. - Google Patents

Compuestos basados en bispidinas, 3,7-diazabiciclo (3,3,1)nonanos, particularmente oxabispidinas, sus sales y solvatos, composiciones conteniéndolos y procedimientos de preparación.

Info

Publication number
UY28959A1
UY28959A1 UY28959A UY28959A UY28959A1 UY 28959 A1 UY28959 A1 UY 28959A1 UY 28959 A UY28959 A UY 28959A UY 28959 A UY28959 A UY 28959A UY 28959 A1 UY28959 A1 UY 28959A1
Authority
UY
Uruguay
Prior art keywords
oxabispidins
bispidins
diazabiciclo
nons
solvates
Prior art date
Application number
UY28959A
Other languages
English (en)
Inventor
Olsson Christina
Annika Bjore
Peter Bonn
Ulrik Gran
Johan Kajanus
Fritiof Ponten
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32710059&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY28959(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY28959A1 publication Critical patent/UY28959A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Se proporcionan compuestos de fórmula I, en donde R1, R2, R3,R4, R41 a R46, A, B y G tienen los significados que se proporcionan en la descripción, que resultan útiles en la profilaxis y en el tratamiento de arritmias, en particular las arritmias atrial y ventricular.
UY28959A 2004-06-15 2005-06-14 Compuestos basados en bispidinas, 3,7-diazabiciclo (3,3,1)nonanos, particularmente oxabispidinas, sus sales y solvatos, composiciones conteniéndolos y procedimientos de preparación. UY28959A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0401539A SE0401539D0 (sv) 2004-06-15 2004-06-15 New compounds

Publications (1)

Publication Number Publication Date
UY28959A1 true UY28959A1 (es) 2006-01-31

Family

ID=32710059

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28959A UY28959A1 (es) 2004-06-15 2005-06-14 Compuestos basados en bispidinas, 3,7-diazabiciclo (3,3,1)nonanos, particularmente oxabispidinas, sus sales y solvatos, composiciones conteniéndolos y procedimientos de preparación.

Country Status (22)

Country Link
US (2) US7648985B2 (es)
EP (1) EP1765832B8 (es)
JP (1) JP2008502678A (es)
KR (1) KR20070039045A (es)
CN (2) CN1968956A (es)
AR (1) AR049823A1 (es)
AU (2) AU2005254924B2 (es)
BR (1) BRPI0512012A (es)
CA (1) CA2568895A1 (es)
DK (1) DK1765832T3 (es)
ES (1) ES2434043T3 (es)
IL (1) IL179560A0 (es)
MX (1) MXPA06014692A (es)
NO (1) NO20070148L (es)
RU (1) RU2379311C9 (es)
SE (1) SE0401539D0 (es)
SG (1) SG153822A1 (es)
TW (1) TW200612907A (es)
UA (1) UA85877C2 (es)
UY (1) UY28959A1 (es)
WO (1) WO2005123748A1 (es)
ZA (2) ZA200610418B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
WO2006135316A1 (en) * 2005-06-13 2006-12-21 Astrazeneca Ab New oxabispidine compounds for the treatment of cardiac arrhythmias
TW200734342A (en) * 2005-12-15 2007-09-16 Astrazeneca Ab New compounds for the treatment of cardiac arrhythmias
MX2010013192A (es) 2008-06-16 2010-12-17 Hoffmann La Roche Monoamidas heteroaromaticas como antagonistas de receptor orexinina.
TW201004963A (en) * 2008-07-03 2010-02-01 Targacept Inc Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands
WO2010059119A1 (en) * 2008-11-21 2010-05-27 Astrazeneca Ab A combination of tert -butyl (2-{7- [2- (4-cyano-2- f luorophenoxy) ethyl] -9-oxa-3, 7-diazabicyclo [3.3.1] non-3- yl } ethyl) carbamate and certain antiarrhythmic benzofurans
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN117384037B (zh) * 2023-12-13 2024-03-08 山东国邦药业有限公司 一种二氟乙酸乙酯的制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196154A (en) 1962-05-17 1965-07-20 Sterling Drug Inc 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US3503939A (en) 1967-03-29 1970-03-31 Du Pont Polyamides from heterocyclic diamines
CH488048A (de) 1969-06-12 1970-03-31 Inventa Ag Verfahren zur Herstellung von Polyesterfasern mit verbesserter Gummihaftung
DE2428792A1 (de) 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
JPS5772977A (en) 1980-10-23 1982-05-07 Dainippon Ink & Chem Inc Fluorine-containing diepoxy compound and its preparation
DE3112055A1 (de) 1981-03-27 1982-10-07 Basf Ag, 6700 Ludwigshafen Bispidinderivate, ihre herstellung und diese enthaltende arzneimittel
DE3234697A1 (de) 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
US4533713A (en) 1983-05-06 1985-08-06 Minnesota Mining And Manufacturing Company Fluoroaliphaticsulfonamides containing oxirane groups and/or N-β-hydroxyalkylene groups
PT88381B (pt) 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE3732094A1 (de) 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5140033A (en) 1989-04-03 1992-08-18 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
US5110933A (en) 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
IL96507A0 (en) * 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
FI100151B (fi) 1992-09-04 1997-09-30 Nokia Mobile Phones Ltd Tehonsäästö matkaviestimessä
US5294621A (en) * 1992-10-07 1994-03-15 Ortho Pharmaceutical Corporation Thieno tetrahydropyridines useful as class III antiarrhythmic agents
JPH06284071A (ja) 1993-01-27 1994-10-07 Casio Comput Co Ltd 無線受信機
US5468858A (en) 1993-10-28 1995-11-21 The Board Of Regents Of Oklahoma State University Physical Sciences N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents
FR2713081B1 (fr) 1993-11-29 1996-01-12 Celsa Lg Filtre sanguin perfectionné à deux séries de pattes en pétales.
US5831099A (en) 1995-03-10 1998-11-03 The United States Of America As Represented By The Secretary Of The Army Compounds of 1,5-disubstituted-3,7 diaza bicyclo 3.3.0! octanes and products containing the same
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
SK13422001A3 (sk) 1999-04-09 2002-05-09 Astrazeneca Ab Adamantánové deriváty
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
AR030756A1 (es) * 2000-10-02 2003-09-03 Astrazeneca Ab Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas
SE0101324D0 (sv) 2001-04-12 2001-04-12 Astrazeneca Ab New process
SE0101327D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab New crystalline forms
SE0101323D0 (sv) 2001-04-12 2001-04-12 Astrazeneca Ab New process
SE0201662D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab Pharmaceutical combination
GB0223712D0 (en) 2002-10-14 2002-11-20 Astrazeneca Ab Chemical intermediate
SE0401540D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds

Also Published As

Publication number Publication date
BRPI0512012A (pt) 2008-02-06
ZA200610418B (en) 2008-07-30
US7648985B2 (en) 2010-01-19
TW200612907A (en) 2006-05-01
UA85877C2 (uk) 2009-03-10
WO2005123748A1 (en) 2005-12-29
EP1765832B1 (en) 2013-08-14
EP1765832B8 (en) 2013-09-25
AU2009222548A1 (en) 2009-10-22
RU2379311C2 (ru) 2010-01-20
JP2008502678A (ja) 2008-01-31
SE0401539D0 (sv) 2004-06-15
RU2379311C9 (ru) 2010-05-27
CN1968956A (zh) 2007-05-23
AU2005254924A1 (en) 2005-12-29
EP1765832A1 (en) 2007-03-28
KR20070039045A (ko) 2007-04-11
US20090270383A1 (en) 2009-10-29
DK1765832T3 (da) 2013-10-21
MXPA06014692A (es) 2007-02-12
US20090005558A1 (en) 2009-01-01
AR049823A1 (es) 2006-09-06
CA2568895A1 (en) 2005-12-29
ES2434043T3 (es) 2013-12-13
CN101525339A (zh) 2009-09-09
AU2005254924B2 (en) 2009-08-27
IL179560A0 (en) 2007-05-15
SG153822A1 (en) 2009-07-29
NO20070148L (no) 2007-01-09
RU2006145202A (ru) 2008-07-20
ZA200710111B (en) 2009-08-26

Similar Documents

Publication Publication Date Title
UY28959A1 (es) Compuestos basados en bispidinas, 3,7-diazabiciclo (3,3,1)nonanos, particularmente oxabispidinas, sus sales y solvatos, composiciones conteniéndolos y procedimientos de preparación.
AR048039A1 (es) Profarmacos de piperazina y agentes antivirales de piperidina sustituidos
AR053569A1 (es) Derivados de pirazol
UY30476A1 (es) Noveles compuestos derivados n-sustituidos de la 3-oxoisoindolin-1-carboxamida, sus sales aceptables, composiciones farmaccuticas y aplicaciones.
GT200600134A (es) Compuestos novedosos de derivados de aminosulfonilo
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
CL2004000076A1 (es) Compuestos derivados de indol, inhibidores de polimerasa, sales; composicion farmaceutica que los comprende; procedimiento de preparacion de dichos compuestos; compuestos intermediarios; y uso del compuesto para tratar una infeccion causada por el vi
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
CL2009001059A1 (es) Compuestos derivados de 1,3-oxazin-2-ona-3,6 sustituidos, inhibidores de la actividad de la 11-beta-hidroxiesteroide deshidrogenasa i; composicion farmaceutica que los comprende; utiles en el tratamiento de enfermedades tales como diabetes mellitus, entre otras.
AR077765A1 (es) Inhibidores de los virus flaviviridae
NO20070089L (no) DPP-IV inhibitorer
CO5700824A2 (es) Nuevos compuestos heterociclicos utiles para el tratamiento de desordenes inflamatorios y alergicos: proceso para su preparacion y composiciones farmaceuticas que los contienen
CO6321248A2 (es) Derivados de triazol utiles para el tratamiento de enfermedades
UY31189A1 (es) Compuestos heterocíclicos
ECSP066855A (es) Derivados de benceno sustituidos por glucopiranosilo, medicamentos que contienen esos compuestos, su aplicación y procedimiento para su preparación
NO20083694L (no) Bruk av rylener som markorer for vaesker
UY31940A (es) Derivados sustituido del 4,5-(sustituido-piridin-3-il)-1-metil-1h-indol, sus sales farmacéuticamente aceptables, polimorfos, rotámeros, pro-fármacos, anantiómeros, hidratos, solvatos del mismo, composiciones conteniéndolos y aplicaciones
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
DOP2006000243A (es) Derivados de pirazina
UY30500A1 (es) Compuestos de azabencimidazolilo
CY1112921T1 (el) Ενεργοποιητες γλυκοκινασης πυρρολιδινονης
AR056860A1 (es) Derivados de triazol inhibidores de receptores de quinasa tgf-beta1, composiciones farmaceuticas que los contienen y usos para el tratamiento de tumores
SE0400043D0 (sv) New compounds
SE0403171D0 (sv) New compounds
CO6341477A2 (es) Compuestos pirrolopirimidincarboxamida, procesos para su producción y composiciones farmaceúticas que comprenden dichos compuestos